Zymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
Zymeworks Appoints Dr. Sabeen Mekan as Senior Vice President, Clinical Development
Zymeworks to Report First Quarter 2025 Financial Results and Host Conference Call on May 8, 2025
Zymeworks to Present at the AACR Oncology Industry Partnering Event
Zymeworks is attending and presenting at the AACR Oncology Industry Partnering Event: From Cancer Discoveries to Patients taking place April 24-25 in Chicago, IL. “We’re excited to participate in this year’s AACR Oncology Industry Partnering Event,” said Lucas Donigian, Vice President, Business and Commercial Development. “This event provides a critical platform for pharmaceutical and biotechnology […]
Zymeworks to Present Preclinical Data on ZW1528 at the American Thoracic Society Annual Meeting
Zymeworks is pleased to announce the acceptance of an abstract for poster presentation featuring preclinical data on ZW1528, a novel IL-4R⍺ x IL-33 bispecific molecule, at the upcoming American Thoracic Society (ATS) Annual Meeting being held May 18-21, 2025 in San Francisco, CA. “We are excited to share preclinical updates on ZW1528, a differentiated bispecific […]
Zymeworks Announces Participation in Upcoming Investor Conferences
Zymeworks to Present Preclinical Data on T cell Engager and Antibody-Drug Conjugate Platforms in Six Posters at AACR Annual Meeting
Zymeworks Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
Zymeworks Announces Achievement of $14 Million Milestone from GSK Collaboration
Zymeworks Announces Participation in Upcoming Investor Conferences
Zymeworks Announces Appointment of Oleg Nodelman to Board of Directors
